Replies to post #66051 on Biotech Values

[rkrw]

That's a basal plus an analog. Is premixed insulin just regular human insulin?

Looks like Sanofi is making a push to angle into novo/lilly dominance.

[gfp927z]

Dew, A question concerning fully diluted share calculations -

If 5 year warrants from a past PIPE expire unexercised, does this reduce the fully diluted share count for the company? (by the amount of the warrant shares that expired).

Thanks for any insights.

[DewDiligence]

SNY’s headline in this PR from ADA is misleading:

http://finance.yahoo.com/news/Sanofi-Announces-Positive-prnews-2993290208.html?x=0&.v=1

Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen

In fact, this open-label study missed its main objective, which was to show that Lantus + Apidra was superior to Novolog 70/30. From the same PR:

The study results supported the non-inferiority of Lantus® plus up to 1 injection of Apidra® versus two–injections of premixed insulin, while in the Lantus® plus up to 3 injections of Apidra® arm, superiority versus premixed insulin was not shown.